Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy.

Saved in:
Bibliographic Details
Title: Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy.
Authors: Wynn, J.1 (AUTHOR) jwynn@billiontoone.com, Rego, S.1 (AUTHOR), Chandler-Brown, D.1 (AUTHOR), Carter, R.1 (AUTHOR), Talati, A.2 (AUTHOR), Zaretsky, M.3 (AUTHOR), Trimble, A.4 (AUTHOR)
Source: Journal of Cystic Fibrosis. Nov2025, Vol. 24 Issue 6, p1067-1072. 6p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first